RE: Some posts today7 Jan 2021 16:39
As someone that often gets vilified as deramping etc, I totally agree DOH.
It's a great RNS and deal for LTH's. Proof of concept for Precision platform. upfront cash, significant milestone cash which equals no risk, little cost, sit back and take a chunk of the royalties, lovely.
Yes, the continued delays to the diagnostics are frustrating (personally think the new strand(s) has pushed us back again...) but with each day that passes Avacta become more and more about the oncology and the pipeline that goes with it.
Too many red hot irons in the fire for this company not to be worth many multiples of the current share price in the years to come, whether that be this year, next year or in 5-10 years....it's surely coming.